ZymoGenetics - Ownership and Business Overview

Life ScienceCompany

ZymoGenetics Ownership

Who owns ZymoGenetics?

ZymoGenetics is owned by Bristol-Myers Squibb. It was acquired on September 7, 2010.

Was ZymoGenetics formerly PE-backed?

Yes. ZymoGenetics was formerly owned by 3 private investors.

ZymoGenetics Business Overview

Where is ZymoGenetics headquartered?

ZymoGenetics is headquartered in Seattle, Washington.

What sector is ZymoGenetics in?

ZymoGenetics is a life science company.

When was ZymoGenetics founded?

ZymoGenetics was founded in 1981.

Life Science M&A Summary in 2010

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2010. The largest life science acquisition in 2010 was Solvay Pharmaceuticals - which was acquired by Abbott Laboratories for $6.1B.

Join Mergr to view all 138 acquisitions of life science companies in 2010, including 15 acquisitions by private equity firms, and 123 by strategics.

ZymoGenetics, Inc.

1201 Eastlake Avenue East,
Seattle, Washington 98102-3702
United States,
(206)442-6600
www.zymogenetics.com

ZymoGenetics, Inc. is a biopharmaceutical company focused on the discovery and development of protein therapeutics that prevent or treat significant human diseases. The company launched its first product on the U.S. market in 2008 and has a strong pipeline of additional products in development.


 Subscribe to unlock this and 208,280
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.